Sodium-glucose linked transporter 2 inhibitor associated post-operative euglycaemic diabetic ketoacidosis: an important consideration for all surgeons.
作者信息
Ahn Thomas, Teloken Patrick, Burke Peter
机构信息
Department of Urology, Greenslopes Private Hospital, Brisbane, Queensland, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
出版信息
ANZ J Surg. 2019 Jul;89(7-8):982. doi: 10.1111/ans.15307.
PMID:31379074
Abstract
摘要
相似文献
1
Sodium-glucose linked transporter 2 inhibitor associated post-operative euglycaemic diabetic ketoacidosis: an important consideration for all surgeons.钠-葡萄糖协同转运蛋白2抑制剂相关的术后正常血糖性糖尿病酮症酸中毒：所有外科医生的重要关注点
ANZ J Surg. 2019 Jul;89(7-8):982. doi: 10.1111/ans.15307.
2
Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin).一名43岁2型糖尿病女性在使用钠-葡萄糖协同转运蛋白2抑制剂（恩格列净）时发生正常血糖性糖尿病酮症酸中毒。
Drug Ther Bull. 2021 Jun;59(6):93-95. doi: 10.1136/dtb.2021.235117rep. Epub 2021 Jan 28.
3
Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin.接受卡格列净治疗的2型糖尿病肥胖手术患者的正常血糖性糖尿病酮症酸中毒
BMJ Case Rep. 2018 Aug 20;2018:bcr-2017-221527. doi: 10.1136/bcr-2017-221527.
4
Diabetic ketoacidosis in patients under treatment with sodium-glucose cotransporter type 2 inhibitors.接受2型钠-葡萄糖协同转运蛋白抑制剂治疗的患者中的糖尿病酮症酸中毒
Med Clin (Barc). 2017 Oct 11;149(7):311-312. doi: 10.1016/j.medcli.2017.05.032. Epub 2017 Jun 27.
5
Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.2型钠-葡萄糖协同转运蛋白抑制剂：应对糖尿病酮症酸中毒这一虽小但关键的风险
Med J Aust. 2020 Apr;212(7):294-296.e1. doi: 10.5694/mja2.50525. Epub 2020 Mar 3.
6
Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.钠-葡萄糖协同转运蛋白 2 抑制剂：药理学和围手术期注意事项。
Anaesthesia. 2018 Aug;73(8):1008-1018. doi: 10.1111/anae.14251. Epub 2018 Mar 12.
7
[Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].[2型糖尿病患者使用SGLT2抑制剂治疗后出现的糖尿病正常血糖性酮症或酮症酸中毒：比利时系列临床病例]
Rev Med Interne. 2020 Apr;41(4):226-231. doi: 10.1016/j.revmed.2019.12.006. Epub 2019 Dec 19.
8
Euglycaemic ketoacidosis from an SGLT2 inhibitor exacerbated by a ketogenic diet.生酮饮食加重SGLT2抑制剂所致的正常血糖性酮症酸中毒
Med J Aust. 2020 Jan;212(1):46-46.e1. doi: 10.5694/mja2.50434. Epub 2019 Dec 1.
9
Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.与钠-葡萄糖共转运蛋白 2 抑制剂相关的围手术期糖尿病酮症酸中毒：系统评价。
Br J Anaesth. 2019 Jul;123(1):27-36. doi: 10.1016/j.bja.2019.03.028. Epub 2019 May 3.
10
Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.一名17岁2型糖尿病青年中糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂使用之间的可能关联
CMAJ. 2021 Sep 7;193(35):E1385-E1388. doi: 10.1503/cmaj.202627.
Zotero 插件